• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经元 KCC2 的治疗潜力不断扩大。

The Expanding Therapeutic Potential of Neuronal KCC2.

机构信息

Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore.

NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 119077, Singapore.

出版信息

Cells. 2020 Jan 17;9(1):240. doi: 10.3390/cells9010240.

DOI:10.3390/cells9010240
PMID:31963584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7016893/
Abstract

Dysfunctions in GABAergic inhibitory neural transmission occur in neuronal injuries and neurological disorders. The potassium-chloride cotransporter 2 (KCC2, SLC12A5) is a key modulator of inhibitory GABAergic inputs in healthy adult neurons, as its chloride (Cl) extruding activity underlies the hyperpolarizing reversal potential for GABA receptor Cl currents (E). Manipulation of KCC2 levels or activity improve symptoms associated with epilepsy and neuropathy. Recent works have now indicated that pharmacological enhancement of KCC2 function could reactivate dormant relay circuits in an injured mouse's spinal cord, leading to functional recovery and the attenuation of neuronal abnormality and disease phenotype associated with a mouse model of Rett syndrome (RTT). KCC2 interacts with Huntingtin and is downregulated in Huntington's disease (HD), which contributed to GABAergic excitation and memory deficits in the R6/2 mouse HD model. Here, these recent advances are highlighted, which attest to KCC2's growing potential as a therapeutic target for neuropathological conditions resulting from dysfunctional inhibitory input.

摘要

GABA 能抑制性神经传递功能障碍发生于神经元损伤和神经紊乱中。钾氯离子共转运蛋白 2(KCC2,SLC12A5)是健康成年神经元中 GABA 能抑制性传入的关键调节物,因为其氯离子(Cl)外排活性为 GABA 受体 Cl 电流(E)的超极化反转电位提供基础。KCC2 水平或活性的操纵可改善与癫痫和神经病变相关的症状。最近的研究表明,药理学增强 KCC2 功能可在受伤的小鼠脊髓中重新激活休眠的中继电路,从而导致功能恢复,并减轻与 Rett 综合征(RTT)小鼠模型相关的神经元异常和疾病表型。KCC2 与亨廷顿蛋白相互作用,并在亨廷顿病(HD)中下调,这导致 R6/2 小鼠 HD 模型中的 GABA 能兴奋和记忆缺陷。在此,强调了这些最新进展,证明 KCC2 作为治疗因抑制性输入功能障碍导致的神经病理学状况的治疗靶标具有越来越大的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0f8/7016893/eb8ff08be0cc/cells-09-00240-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0f8/7016893/eb8ff08be0cc/cells-09-00240-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0f8/7016893/eb8ff08be0cc/cells-09-00240-g001.jpg

相似文献

1
The Expanding Therapeutic Potential of Neuronal KCC2.神经元 KCC2 的治疗潜力不断扩大。
Cells. 2020 Jan 17;9(1):240. doi: 10.3390/cells9010240.
2
Crossing the Chloride Channel: The Current and Potential Therapeutic Value of the Neuronal K-Cl Cotransporter KCC2.穿越氯离子通道:神经元 K-Cl 协同转运蛋白 KCC2 的电流和潜在治疗价值。
Biomed Res Int. 2019 May 21;2019:8941046. doi: 10.1155/2019/8941046. eCollection 2019.
3
Restoring GABAergic inhibition rescues memory deficits in a Huntington's disease mouse model.恢复 GABA 能抑制可挽救亨廷顿病小鼠模型中的记忆缺陷。
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1618-E1626. doi: 10.1073/pnas.1716871115. Epub 2018 Jan 30.
4
The Therapeutic Potential of Neuronal K-Cl Co-Transporter KCC2 in Huntington's Disease and Its Comorbidities.神经元 K-Cl 协同转运蛋白 KCC2 在亨廷顿病及其共病中的治疗潜力。
Int J Mol Sci. 2020 Nov 30;21(23):9142. doi: 10.3390/ijms21239142.
5
The Role of K-Cl-Cotransporter-2 in Neuropathic Pain.K-Cl 协同转运蛋白 2 在神经病理性疼痛中的作用。
Neurochem Res. 2018 Jan;43(1):110-115. doi: 10.1007/s11064-017-2344-3. Epub 2017 Jul 4.
6
Role of the potassium chloride cotransporter isoform 2-mediated spinal chloride homeostasis in a rat model of visceral hypersensitivity.氯化钾协同转运蛋白亚型2介导的脊髓氯稳态在内脏超敏反应大鼠模型中的作用
Am J Physiol Gastrointest Liver Physiol. 2015 May 1;308(9):G767-78. doi: 10.1152/ajpgi.00313.2014. Epub 2015 Mar 19.
7
Pathogenic potential of human SLC12A5 variants causing KCC2 dysfunction.导致 KCC2 功能障碍的人类 SLC12A5 变体的致病潜力。
Brain Res. 2019 May 1;1710:1-7. doi: 10.1016/j.brainres.2018.12.025. Epub 2018 Dec 18.
8
Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.通过 KCC2 操作重新激活受损脊髓中的休眠中继途径。
Cell. 2018 Jul 26;174(3):521-535.e13. doi: 10.1016/j.cell.2018.06.005. Epub 2018 Jul 19.
9
Neuronal K-Cl cotransporter KCC2 as a promising drug target for epilepsy treatment.神经元 K-Cl 协同转运蛋白 KCC2 作为治疗癫痫的有希望的药物靶点。
Acta Pharmacol Sin. 2024 Jan;45(1):1-22. doi: 10.1038/s41401-023-01149-9. Epub 2023 Sep 13.
10
Seizing Control of KCC2: A New Therapeutic Target for Epilepsy.控制 KCC2:癫痫治疗的新靶点。
Trends Neurosci. 2017 Sep;40(9):555-571. doi: 10.1016/j.tins.2017.06.008. Epub 2017 Aug 10.

引用本文的文献

1
Potentiation of group III metabotropic glutamate receptors positively affects neurophysiological features in a mouse model of Rett syndrome.III 型代谢型谷氨酸受体的增强对雷特综合征小鼠模型的神经生理特征产生积极影响。
J Pharmacol Exp Ther. 2025 Jun;392(6):103602. doi: 10.1016/j.jpet.2025.103602. Epub 2025 May 8.
2
Impaired Molecular Mechanisms Contributing to Chronic Pain in Patients with Hidradenitis Suppurativa: Exploring Potential Biomarkers and Therapeutic Targets.化脓性汗腺炎患者慢性疼痛相关分子机制受损:探索潜在生物标志物和治疗靶点。
Int J Mol Sci. 2025 Jan 25;26(3):1039. doi: 10.3390/ijms26031039.
3
Uncovering novel KCC2 regulatory motifs through a comprehensive transposon-based mutant library.

本文引用的文献

1
FLT3 mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development.急性髓系白血病中的 FLT3 突变:超越抑制剂开发的治疗范例。
Cancer Sci. 2020 Feb;111(2):312-322. doi: 10.1111/cas.14274. Epub 2019 Dec 30.
2
Calpain fosters the hyperexcitability of motoneurons after spinal cord injury and leads to spasticity.钙蛋白酶促进脊髓损伤后运动神经元的过度兴奋,并导致痉挛。
Elife. 2019 Dec 9;8:e51404. doi: 10.7554/eLife.51404.
3
Identification of KCC2 Mutations in Human Epilepsy Suggests Strategies for Therapeutic Transporter Modulation.
通过全面的基于转座子的突变体文库揭示新型KCC2调控基序。
Front Mol Neurosci. 2025 Jan 15;17:1505722. doi: 10.3389/fnmol.2024.1505722. eCollection 2024.
4
Development of KCC2 therapeutics to treat neurological disorders.开发用于治疗神经系统疾病的KCC2疗法。
Front Mol Neurosci. 2024 Dec 10;17:1503070. doi: 10.3389/fnmol.2024.1503070. eCollection 2024.
5
Continuous Use During Disuse: Mechanisms and Effects of Spontaneous Activity of Unloaded Postural Muscle.连续使用与停用期间:非负重姿势肌肉自发性活动的机制和影响。
Int J Mol Sci. 2024 Nov 20;25(22):12462. doi: 10.3390/ijms252212462.
6
Novel voltage-dependent Cl channels in striatal medium spiny neurons are unrelated to ClC-1 or other known Ca-induced Cl channel/transporter types.纹状体中间神经元中新的电压依赖性 Cl 通道与 ClC-1 或其他已知的 Ca2+诱导的 Cl 通道/转运体类型无关。
Neurosci Lett. 2025 Jan 1;844:138032. doi: 10.1016/j.neulet.2024.138032. Epub 2024 Nov 2.
7
Unraveling the socio-cognitive consequences of KCC2 disruption in zebrafish: implications for neurodevelopmental disorders and therapeutic interventions.揭示斑马鱼中KCC2破坏的社会认知后果:对神经发育障碍和治疗干预的影响。
Front Mol Neurosci. 2024 Oct 14;17:1483238. doi: 10.3389/fnmol.2024.1483238. eCollection 2024.
8
New epilepsy therapies in development.正在开发的新癫痫疗法。
Nat Rev Drug Discov. 2024 Sep;23(9):682-708. doi: 10.1038/s41573-024-00981-w. Epub 2024 Jul 22.
9
Expanding the clinical and genetic landscape of (developmental) epileptic encephalopathy with spike-and-wave activation in sleep: results from studies of a Turkish cohort.拓展具有睡眠中棘慢波放电的(发育性)癫痫性脑病的临床和遗传图谱:来自土耳其队列研究的结果。
Neurogenetics. 2024 Apr;25(2):119-130. doi: 10.1007/s10048-024-00751-1. Epub 2024 Feb 22.
10
High Doses of ANA12 Improve Phenobarbital Efficacy in a Model of Neonatal Post-Ischemic Seizures.高剂量 ANA12 可提高新生儿缺血性癫痫模型中苯巴比妥的疗效。
Int J Mol Sci. 2024 Jan 24;25(3):1447. doi: 10.3390/ijms25031447.
人类癫痫中KCC2突变的鉴定为治疗性转运体调节提供了策略。
Front Cell Neurosci. 2019 Nov 15;13:515. doi: 10.3389/fncel.2019.00515. eCollection 2019.
4
KCC2 expression levels are reduced in post mortem brain tissue of Rett syndrome patients.KCC2 的表达水平在 Rett 综合征患者的尸检脑组织中降低。
Acta Neuropathol Commun. 2019 Dec 3;7(1):196. doi: 10.1186/s40478-019-0852-x.
5
Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence.运动表现型亨廷顿病中的轻度认知障碍和痴呆:分类和患病率。
J Neurol Sci. 2020 Jan 15;408:116523. doi: 10.1016/j.jns.2019.116523. Epub 2019 Oct 15.
6
The Molecular Basis of MeCP2 Function in the Brain.大脑中MeCP2功能的分子基础。
J Mol Biol. 2020 Mar 13;432(6):1602-1623. doi: 10.1016/j.jmb.2019.10.004. Epub 2019 Oct 17.
7
Developmentally regulated KCC2 phosphorylation is essential for dynamic GABA-mediated inhibition and survival.发育调控的 KCC2 磷酸化对于动态 GABA 介导的抑制和存活是必需的。
Sci Signal. 2019 Oct 15;12(603):eaaw9315. doi: 10.1126/scisignal.aaw9315.
8
Impaired regulation of KCC2 phosphorylation leads to neuronal network dysfunction and neurodevelopmental pathology.KCC2 磷酸化调节受损导致神经元网络功能障碍和神经发育病理学。
Sci Signal. 2019 Oct 15;12(603):eaay0300. doi: 10.1126/scisignal.aay0300.
9
Γ-Aminobutyric acid in adult brain: an update.成人脑中的 γ-氨基丁酸:更新。
Behav Brain Res. 2019 Dec 30;376:112224. doi: 10.1016/j.bbr.2019.112224. Epub 2019 Sep 10.
10
Developmental Regulation of KCC2 Phosphorylation Has Long-Term Impacts on Cognitive Function.KCC2磷酸化的发育调控对认知功能有长期影响。
Front Mol Neurosci. 2019 Jul 23;12:173. doi: 10.3389/fnmol.2019.00173. eCollection 2019.